Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine

By Yung C.Y.   Yoshimatsu K.   Koike Y.   Hatsuse R.   Yamanishi K.   Tanishita O.   Arikawa J.   Azuma I.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 216-224

Elsevier

Access to resources Recommend Favorite

The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age

By Hirota Y.   Kaji M.   Ide S.   Goto S.   Oka T.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1597-1602

Elsevier

Access to resources Recommend Favorite

Inactivated hepatitis A vaccine: long-term antibody persistence

By Wiedermann G.   Kundi M.   Ambrosch F.   Safary A.   D'Hondt E.   Delem A.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 612-615

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience

By Pittman P.R.   Liu C.T.   Cannon T.L.   Makuch R.S.   Mangiafico J.A.   Gibbs P.H.   Peters C.J.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 181-189

Elsevier

Access to resources Recommend Favorite

Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax(R)) in children and adults

By Krah D.L.   Cho I.   Schofield T.   Ellis R.W.  

Vaccine, Vol. 15, Iss. 1, 1997-01 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite